212 - HEART VALVE DISEASE IN CANADA - RECOMMENDED COMPONENTS FOR A NATIONAL STRATEGY

Sunday, October 30, 2022

8:30 AM – 9:15 AM EDT

Location: Room 214

Target Audience: General: All cardiovascular (clinical and research) health professionals

Chair(s)

DM

David Messika-Zeitoun, MD, PhD, FESC

Cardiologist
University of Ottawa Heart Institute
University of Ottawa Heart Institute
Ottawa, Ontario, Canada

Co-Chair(s)

Jessica Forcillo, MD-MSc MPH FRCSC

Cardiac surgeon
CSCS
Centre Hospitalier de l'Université de Montréal
Montreal, Quebec, Canada
David Wood, MD, FRCPC, FACC, FESC

Professor of Medicine, UBC
CAIC
University of British Columbia
Vancouver, British Columbia, Canada

Presenter(s)

Anita Asgar, MD, MSc

Interventional Cardiologist
Montreal Heart Institute
Université de Montréal
Montréal, Quebec, Canada
Edgar Chedrawy, MD

Cardiac Surgeon
CSCS
Dalhousie University
Halifax, Nova Scotia, Canada
Janine Eckstein

Assistant Professor
University of Saskatchewan
University of Saskatchewan
Saskatoon, Saskatchewan, Canada
Dr. Jean-Francois Legare, MD MSc

Medical Director
New Brunswick Heart Centre
Dalhousie University Medicine New Brunswick
Saint John, New Brunswick, Canada
Madhu K. Natarajan, MD, MSc

Interventional Cardiologist
CAIC
McMaster University
Hamilton, Ontario, Canada
Philippe Pibarot

Head of Cardiology Research
Institut Universitaire de Cardiologie de Québec
Université Laval
Laval, Quebec, Canada
RS

Rima Styra

Clinical Investigator
Toronto, Ontario, Canada
BT

Benjamin Tyrrell

Cardiologist
Edmonton,, Alberta, Canada

Planning Committee Member(s)

Najah Adreak

MD,MSc, Study Coordinator
The university of British Columbia/ BC Chidren Hospital
The univeristy of British Columbia
Burnaby, British Columbia, Canada
SG

Sharon Groulx

Project Manager
Ottawa, Ontario, Canada
KP

Kendra Pelland

Program Manager
Canadian Cardiovascular Society
Ottawa, Ontario, Canada
Carolyn Pullen

Chief Executive Officer
Canadian Cardiovascular Society
Ottawa, Ontario, Canada

Learning Objectives:

At the conclusion of this session, participants will be able to:

quantify the growing epidemics of heart valve diseases;
identify the main gaps in the current management of patients with heart valve diseases;
quantify disparities in access to care and innovation across Canada; and
cite the main Components Recommended for a National Strategy.

Following two rounds tables involving various stakeholders, the Institute of Health Economics has recently released a white paper on Heart Valve Diseases in Canada, Recommended Components for a National Strategy. This white paper is endorsed by the new CCS working on Heart Valve Diseases.

The aims of the workshop is

to describe the burden of heart valve diseases, the epidemics
to highlight the importance of detection and screening at the primary and cardiology care level
to discuss the need for specific referral pathways and evidence regarding value of heart valve disease clinic
to present the main components of the white paper.